European Archives - Page 1040 of 1158 - European Medical Journal

Continue
19 Apr 2016

Treatment Strategies for TRAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Helen Lachmann…
19 Apr 2016

Treatments for Patients with CAPS

At the American College of Rheumatology Annual Meeting, which took place in San Francisco, California, USA, from 6 to 11 November 2015, Jasmin Kuemmerle…
EMJ
19 Apr 2016

Structure of Coronavirus Defence Offers Clues to Treatment

DECIPHERING the structure of a key protein in the coronavirus HKU1, a member of a family of deadly viruses, has provided a promising avenue for…
EMJ
19 Apr 2016

First 3D Printed ‘Sneezometer’ Opens Doors to Diagnosis

PIONEERING use of 3D printing technology has enabled the development of simple, non-intrusive, and cost-effective spirometry for the diagnosis of…
EMJ
15 Apr 2016

EULAR Crowdsources Inspirational Stories to Educate the World about Rheumatic and Musculoskeletal Diseases

Sofia, Bulgaria (15 April 2016): EULAR and the Standing Committee of PARE (People with Arthritis/Rheumatism) has launched ‘The Future In Your Hands’…
EMJ
15 Apr 2016

UK Study Shows Rifaximin-α Significantly Reduces Hospital Resource Use for Patients with Hepatic Encephalopathy

LONDON, UK, Thursday 14 April, 07:00 BST: Norgine B.V. presented new positive UK real world practice data from the IMPRESS retrospective observational…
EMJ
15 Apr 2016

Celyad Will Present Its NKR-2 Immuno-Oncology Clinical Program at 2016 ASCO Annual Meeting

Mont-Saint-Guibert, Belgium: Celyad (Euronext Brussels and Paris, and NASDAQ: CYAD), a leader in the discovery and development of engineered cell…
EMJ
15 Apr 2016

Patients with EGFR Expressing Non-Small-Cell Lung Cancer Benefit Most from Necitumumab Added to Chemotherapy

GENEVA, Switzerland, 15 April 2016: Patients with epidermal growth factor receptor (EGFR) expressing advanced squamous non-small-cell lung cancer benefit…
EMJ
15 Apr 2016

Immunotherapy with Live Bacterium Improves Response Rate in Malignant Pleural Mesothelioma

GENEVA, Switzerland, 14 April 2016: Immunotherapy with a live bacterium combined with chemotherapy demonstrated more than 90% disease control and…
EMJ
15 Apr 2016

Osimertinib given as First-Line Treatment May Alter Biology of EGFR Mutated Non-Small-Cell Lung Cancer

GENEVA, Switzerland, 14 April 2016 – The third generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is…
We’ve noticed you’re accessing
from North/South America.